Survival in prostate carcinoma - Outcomes from a prospective, population-based cohort of 8887 men with up to 15 years of follow-up: Results from three counties in the population-based national prostate cancer registry of Sweden

Cancer

Volumn 103, Issue 5, 2005, Pages 943-951

  Aus, Gunnar ^a   Robinson, David ^b   Rosell, Johan ^c   Sandblom, Gabriel ^d   Varenhorst, Eberhard ^e  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b RYHOV COUNTY HOSPITAL   (Sweden)

^c LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^d UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^e VRINNEVI HOSPITAL   (Sweden)

Author keywords

Prostate carcinoma; Registries; Survival; Therapy

Indexed keywords

ANTIANDROGEN; GONADORELIN DERIVATIVE; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; CAUSE OF DEATH; COHORT ANALYSIS; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; ORCHIECTOMY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CARCINOMA; PROSTATECTOMY; STATISTICAL ANALYSIS; SURVIVAL RATE; SWEDEN;

ADULT; AGED; COHORT STUDIES; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; REGISTRIES; SURVIVAL RATE; SWEDEN;

EID: 13944258110     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.20855     Document Type: Article

References (18)

1. Oliver SE, May MT, Gunnell D. International trends in prostate-cancer mortality in the "PSA-era." Int J Cancer. 2001; 92:893-898.
2. Helgesen F, Holmberg L, Johansson JE, Bergstrom R, Adami HO. Trends in prostate cancer survival in Sweden, 1960 through 1988, evidence of increasing diagnosis of nonlethal tumors. J Natl Cancer Inst. 1996;88:1216-1221.
3. Post PN, Kil PJ, Coebergh JW. Trends in survival of prostate cancer in southeastern Netherlands 1971-1989. Int J Cancer. 1999;81:551-554.
4. Sandblom G, Dufmats M, Nordenskjold K, Varenhorst E. Prostate carcinoma trends in three counties in Sweden 1987-1966. Results from a population-based national cancer register. Cancer. 2000;88:1445-1453.
5. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J, editors. Cancer incidence in five continents. Volume VII. IARC Scientific Pub. No. 120. Lyon: International Agency for Research on Cancer, 1997.
6. Statistics Sweden (Statistiska Centralbyrån). Population statistics. [Monograph online]. Available from URL: www.scb.se [accessed March 1, 2004].
7. Sobin LH, Wittekind C, editors. TNM classification of malignant tumors, 5th edition. New York: John Wiley & Sons, 1997.
8. Sandblom G, Dufmats M, Olsson M, Varenhorst E. Validity of a population-based cancer register in Sweden. An assessment of data reproducibility in the South-East Region Prostate Cancer Register. Scand J Urol Nephrol. 2002;37:112-119.
9. Hugosson J, Aus G, Lilja H, Lodding P, Pihl C-G. Results of a randomized, population-based study of biennial screening using serum prostate-specific antigen measurement to defect prostate carcinoma. Cancer. 2004;100:1397-1405.
10. Johansson JE, Holmberg L, Johansson S, Bergström R, Adami HO. Fifteen-year survival in prostate cancer. A prospective, population-based study in Sweden. JAMA. 1997; 277:467-471.
11. Smith DS, Catalona WJ, Herschman JD. Longitudinal screening for prostate cancer with prostate specific antigen. JAMA. 1996;276:1309-1315.
12. Labrie F, Candas B, Cusan L, et al. Diagnosis of advanced or noncurable prostate cancer can be practically eliminated by prostate-specific antigen. Urology. 1996:47:212-217.
13. Holmberg L, Bill-Axelsson A, Helgesen F, et al. A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. N Engl J Med. 2002;347:781-789.
14. Zincke H, Bergstralh EJ, Blute MI, et al. Radical prostatectomy for clinically localized prostate cancer: long-term results of 1143 patients from a single institution. J Clin Oncol. 1994;12:2254-2263.
15. Han M, Partin AW, Zahurak M, Piantadosi S, Epstein JI, Walsh PC. Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer. J Urol. 2003;169:517-523.
16. Barry MJ, Albertsen PC, Bagshaw MA, et al. Outcomes for men with clinically non-metastatic prostate carcinoma managed with radical prostatectomy, external beam radiotherapy, or expectant management: a retrospective analysis. Cancer. 2001;91:2302-2314.
17. Pollack A, Zagars GK, Starkschall G, et al. Prostate cancer radiation dose response: results of the M. D. Anderson Phase III randomized trial. Int J Radiat Oncol Biol Phys. 2002;53:1097-1105.
18. Zietman AL, Chung CS, Coen JJ, Shipley WU. 10-year outcome for men with localized prostate cancer treated with external radiation therapy: results of a cohort study. J Urol. 2004;171:210-214.